Pfizer to further reduce stake in Haleon, offers to sell 540 million share
Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, the statement shows. The offering and buyback together would reduce Pfizer’s stake in the maker of Sensodyne toothpaste to 16.2% from 22.6%.
59mon MSN
Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...
No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Drugs giant struggling to manage slump in demand for Covid vaccines and antivirals as it falls behind rivals on obesity ...
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
Pharmaceutical firm Pfizer is to cut more jobs at its Irish manufacturing facilities, as part of a global cost-cutting ...
Huge multinational Pharmaceutical firm Pfizer is set to cut 210 across their facilities in Ireland. The firm is understood to ...
Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback